Celltrion
🇰🇷 South Korea · Biopharmaceuticals · 068270.KS
Biosimilar developer and manufacturer.
Market capitalization
USD 27.3B
2025
+3.4%
2024→2025
| 2020 | USD 45.1B |
| 2021 | USD 23.2B |
| 2022 | USD 18.1B |
| 2023 | USD 33.5B |
| 2024 | USD 26.4B |
| 2025 | USD 27.3B |
Source: companiesmarketcap.com — Celltrion
All top companies in 🇰🇷 South Korea→